5PSQ-177 Cardiovascular risk and altered lipid profile associated with treatment with the kinase JAK inhibitors, tofacitinib and baricitinib

Added 474 days ago (28.04.2021)
Authors: Cantarelli, L., Navarro Davila, M., Calzado Gomez, G., Gutierrez Nicolas, F., Nazco Casariego, G.
Read article